Reuters: Bill Smead on Merck Sales Forecast for 2023
 Merck raises 2023 sales forecast as top drugs beat Street estimates By Michael Erman and Leroy Leo For more information go to reuters.com. Stocks mentioned: MRK The information contained in this tv appearance represents SCM’s opinions, and should not be construed as personalized or